v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   126,106,176      
Beginning balance at Dec. 31, 2024 $ 208,730 $ 13 $ 481,679 $ 57 $ (273,019)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of vested stock options (in shares)   42,293      
Issuance of common stock upon exercise of vested stock options 18   18    
Stock-based compensation 2,168   2,168    
Other comprehensive income (loss) 132     132  
Net loss (16,613)       (16,613)
Ending balance (in shares) at Mar. 31, 2025   126,148,469      
Ending balance at Mar. 31, 2025 $ 194,435 $ 13 483,865 189 (289,632)
Beginning balance (in shares) at Dec. 31, 2025 126,469,610 126,469,610      
Beginning balance at Dec. 31, 2025 $ 156,973 $ 13 488,737 243 (332,020)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of vested stock options (in shares) 600,870 600,870      
Issuance of common stock upon exercise of vested stock options $ 1,105   1,105    
Stock-based compensation 1,368   1,368    
Other comprehensive income (loss) (334)     (334)  
Net loss $ (14,697)       (14,697)
Ending balance (in shares) at Mar. 31, 2026 127,070,480 127,070,480      
Ending balance at Mar. 31, 2026 $ 144,415 $ 13 $ 491,210 $ (91) $ (346,717)